Latest Breaking News On - Arati rao - Page 4 : vimarsana.com

Vial welcomes Dr Luke Nordquist of XCancer and UCC to Vial s Oncology CRO Advisory Board

/PRNewswire/ Vial is welcoming Dr. Luke Nordquist to Vial s Oncology Scientific Advisory Board. Dr. Nordquist is the latest addition to the board after Dr..

Antoni ribasArvind chaudhryArati raoLuke nordquistContract research organizationXcancer research networkUrology cancer center gu research networkOncology scientific advisoryGuru sonpavdeVial oncologyResearch networkUrology cancer centerResearch organization

Vial adds Dr Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board

BioPharma

Antoni ribasArati raoProfessor of medicine at harvard medical schoolHarvard medical schoolDana farber cancer instituteGenitourinary committee of southwest oncology groupGuru sonpavdeBladder cancer directorAssociate professorAdvisory boardNeeraj agarwalGenitourinary committeeSouthwest oncology groupBladder cancer task forceNational cancer institute genitourinary steering

Vial adds Dr Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board

/PRNewswire/ Dr. Guru Sonpavde is the Bladder Cancer Director at the Dana-Farber Cancer Institute, an Associate Professor of Medicine at Harvard Medical.

Antoni ribasArati raoContract research organizationDana farber cancer instituteProfessor of medicine at harvard medical schoolHarvard medical schoolGenitourinary committee of southwest oncology groupGuru sonpavdeBladder cancer directorAssociate professorAdvisory boardNeeraj agarwalGenitourinary committeeSouthwest oncology groupBladder cancer task forceNational cancer institute genitourinary steering

Vial adds Dr Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board

Vial adds Dr Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Antoni ribasArati raoDana farber cancer instituteProfessor of medicine at harvard medical schoolHarvard medical schoolGenitourinary committee of southwest oncology groupGuru sonpavdeBladder cancer directorAssociate professorAdvisory boardNeeraj agarwalGenitourinary committeeSouthwest oncology groupBladder cancer task forceNational cancer institute genitourinary steering

Vial adds Dr Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board

/PRNewswire/ Dr. Guru Sonpavde is the Bladder Cancer Director at the Dana-Farber Cancer Institute, an Associate Professor of Medicine at Harvard Medical.

Antoni ribasArati raoContract research organizationDana farber cancer instituteProfessor of medicine at harvard medical schoolHarvard medical schoolGenitourinary committee of southwest oncology groupGuru sonpavdeBladder cancer directorAssociate professorAdvisory boardNeeraj agarwalGenitourinary committeeSouthwest oncology groupBladder cancer task forceNational cancer institute genitourinary steering